ribociclib
novartis
['bcsm', 'breast', ' ribo', 'ribociclib']
adding ribociclib to endocrine therapy yields 25% relative reduction in risk of invasive disease in patients with hr+/her2 early breast cancer #oncology #nursing #bcsm #asco23 
Capturing the voice of nursing professionals in the oncology news landscape.